Publication | Closed Access

A phase II study of irinotecan in children with relapsed or refractory neuroblastoma: A European cooperation of the Société Française d’Oncologie Pédiatrique (SFOP) and the United Kingdom Children Cancer Study Group (UKCCSG)

Pediatric Brain TumorsMalignant DiseaseRefractory NeuroblastomaMedicineEuropean CooperationPathologyPhase Ii StudyCancer TreatmentOncologyRadiation OncologyCancer Research